growth guidanc seem reflect
in-lin disappoint margin guidanc organ
growth histor level growth consensu compani
repeat noth new big pharma weak china still reorgan food
safeti agenc weak industri demand
glass half full show govern academ growth european
growth mid-term goal achiev histor organ growth addit
compani spend share buyback see sustain new
share price valuat seem reflect slower peer growth rate
valu compar peer averag addit debt
capac avail continu share repurchas
valuat lower fair valu per share base
pe ratio reduc earn estim
subtract net debt pe assumpt reflect
year pe rang fair valu also reflect ev/ebitda valu
estim compar peer
million except per share data
organ year
total sale
amort intang other
annual revenu break-out margin
total sale
amort intangilb
revenu
